The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing subjectivity into what should be an objective process.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-changes-drug-trial-guidance-experts-take-sides-2026a100051r?src=rss
Author :
Publish date : 2026-02-18 06:40:00
Copyright for syndicated content belongs to the linked Source.
